Tag: next-generation sequencing

Nick Beckloff, PhD, PMP: Bridging Science, Strategy, and Commercialization to Turn Innovation Into Impact

Throughout my career, I’ve had the opportunity to work across genomics, life sciences, laboratory operations, bioinformatics, commercialization, strategic partnerships, project management, and emerging AI technologies. Each experience has reinforced my belief that some of the greatest opportunities emerge when we successfully connect science, technology, business strategy, and the people responsible for turning ideas into meaningful outcomes. As I continue exploring opportunities to contribute through board and advisory service, I’m pleased to share more about the experiences and values that have shaped my professional journey. Here is my biography.

Matthew Smollin, PharmD: A Pioneering Leader in Medical Affairs and Clinical Innovation

Matthew Smollin, PharmD, is an accomplished leader in medical affairs and clinical innovation with over 15 years of clinical experience and a decade of industry expertise spanning clinical research, regulatory strategy, and team leadership. As Vice President of Medical Affairs at Karius, Inc., he directs medical and scientific strategies, guiding breakthrough advancements in molecular diagnostics while navigating complex FDA and Medicare regulatory processes. Throughout his career, he has successfully built and managed high-performing teams, fostered strong relationships with key opinion leaders, and played a pivotal role in clinical trial design, publication strategy, and scientific engagement. A respected speaker and thought leader, Dr. Smollin’s expertise in infectious disease diagnostics and next-generation sequencing has shaped industry best practices and advanced clinical innovation. His dedication to scientific excellence, strategic vision, and ability to translate complex medical insights into impactful solutions make him a driving force in the evolution of precision medicine and diagnostic technologies.